Fineline Cube

Follow:
14778 Articles
NMPA Grants Conditional Approval for China's First MSCs Therapy for aGVHD
CompanyDrug

NMPA Grants Conditional Approval for China’s First MSCs Therapy for aGVHD

Genesis MedTech's iReach Omnia Receives NMPA Approval for Rectal Cancer Surgery
CompanyMedical Device

Genesis MedTech’s iReach Omnia Receives NMPA Approval for Rectal Cancer Surgery

Eli Lilly & Co. Launches Mounjaro (Tirzepatide) in China for Diabetes and Weight Management
CompanyDrug

Eli Lilly & Co. Launches Mounjaro (Tirzepatide) in China for Diabetes and Weight Management

Prime Gene Therapeutics Secures Over RMB300 Million in Series B Financing
CompanyDeals

Prime Gene Therapeutics Secures Over RMB300 Million in Series B Financing

Brii Biosciences to Acquire Full Rights to BRII-179 from VBI Vaccines
CompanyDeals

Brii Biosciences to Acquire Full Rights to BRII-179 from VBI Vaccines

Shanghai Pharmaceuticals Halts Development of I001-B, I022, and C012 in the US
CompanyDrug

Shanghai Pharmaceuticals Halts Development of I001-B, I022, and C012 in the US

Astellas Pharma's Vyloy Approved by NMPA for CLDN18.2 Positive Gastric Cancer
CompanyDrug

Astellas Pharma’s Vyloy Approved by NMPA for CLDN18.2 Positive Gastric Cancer

Sichuan Kelun-Biotech's Ketailai Receives NMPA Approval for Nasopharyngeal Carcinoma Treatment
CompanyDrug

Sichuan Kelun-Biotech’s Ketailai Receives NMPA Approval for Nasopharyngeal Carcinoma Treatment

Sino Biopharmaceutical's Chia Tai Tianqing Secures Exclusive Promotion Rights for Naldemedine in China
CompanyDeals

Sino Biopharmaceutical’s Chia Tai Tianqing Secures Exclusive Promotion Rights for Naldemedine in China

HutchMed's Orpathys Receives Priority Review for NSCLC Treatment in China
CompanyDrug

HutchMed’s Orpathys Receives Priority Review for NSCLC Treatment in China

Innovent Biologics Strikes Licensing Deal with Roche for IBI3009 ADC
CompanyDeals

Innovent Biologics Strikes Licensing Deal with Roche for IBI3009 ADC

Maxvax Biotechnology Secures RMB 200 Million in Convertible Bonds Financing
CompanyDeals

Maxvax Biotechnology Secures RMB 200 Million in Convertible Bonds Financing